01 12Pfizer Canada Inc.
02 5Blank
01 52018287
02 42086642
03 12133175
04 12133177
05 32230748
06 32293793
01 12Sirolimus
02 5Blank
01 3Oral Solution
02 9Tablet
03 5Blank
01 52010-06-05
02 42013-01-04
03 22014-09-28
04 32018-03-02
05 32018-06-11
Patent Expiration Date : 2018-03-02
Date Granted : 2010-08-03
Brand Name : RAPAMUNE
Patent Number : 2230748
Filing Date : 1998-03-02
Strength per Unit : 2 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-03-02
Date Granted : 2010-08-03
Patent Expiration Date : 2018-03-02
Date Granted : 2010-08-03
Brand Name : RAPAMUNE
Patent Number : 2230748
Filing Date : 1998-03-02
Strength per Unit : 5 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-03-02
Date Granted : 2010-08-03
Patent Expiration Date : 2018-03-02
Date Granted : 2010-08-03
Brand Name : RAPAMUNE
Patent Number : 2230748
Filing Date : 1998-03-02
Strength per Unit : 1mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-03-02
Date Granted : 2010-08-03
Patent Expiration Date : 2013-01-04
Date Granted : 2004-06-15
Brand Name : RAPAMUNE
Patent Number : 2086642
Filing Date : 1993-01-04
Strength per Unit : 1.0 mg / ml
Dosage Form : Oral Solution
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2013-01-04
Date Granted : 2004-06-15
Patent Expiration Date : 2014-09-28
Date Granted : 2004-08-17
Brand Name : RAPAMUNE
Patent Number : 2133175
Filing Date : 1994-09-28
Strength per Unit : 1.0 mg / ml
Dosage Form : Oral Solution
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2014-09-28
Date Granted : 2004-08-17
Patent Expiration Date : 2014-09-28
Date Granted : 2004-08-17
Brand Name : RAPAMUNE
Patent Number : 2133177
Filing Date : 1994-09-28
Strength per Unit : 1.0 mg / ml
Dosage Form : Oral Solution
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2014-09-28
Date Granted : 2004-08-17
Patent Expiration Date : 2018-06-11
Date Granted : 2006-07-11
Brand Name : RAPAMUNE
Patent Number : 2293793
Filing Date : 1998-06-11
Strength per Unit : 2 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-06-11
Date Granted : 2006-07-11
Patent Expiration Date : 2013-01-04
Date Granted : 2006-06-15
Brand Name : RAPAMUNE
Patent Number : 2086642
Filing Date : 1993-01-04
Strength per Unit : 2 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2013-01-04
Date Granted : 2006-06-15
Patent Expiration Date : 2018-06-11
Date Granted : 2006-07-11
Brand Name : RAPAMUNE
Patent Number : 2293793
Filing Date : 1998-06-11
Strength per Unit : 5 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-06-11
Date Granted : 2006-07-11
Patent Expiration Date : 2013-01-04
Date Granted : 2004-06-15
Brand Name : RAPAMUNE
Patent Number : 2086642
Filing Date : 1993-01-04
Strength per Unit : 5 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2013-01-04
Date Granted : 2004-06-15
